CTC Alternative Strategies, Ltd.

Position in BMY — Bristol Myers Squibb Co

CIK 1569550 CHICAGO, IL

Position in BMY

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$207,432

-$56,421 QoQ

Shares Held

3,600

-36.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.44%

of 13F equity value

Holder Rank

#2,136

of 2,506 holders

Holding Since

Jun 2024

4 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CTC Alternative Strategies, Ltd. holds $4,726,536 across 6 Drug Manufacturers - General names. BMY ranks #6 (4.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	11,400	$2,868,696
2	LLY	ELI LILLY & Co	560	$671,680
3	GILD	Gilead Sciences, Inc.	3,000	$379,020
4	JNJ	Johnson & Johnson	1,400	$355,558
5	MRK	Merck & Co., Inc.	1,900	$244,150
6	BMY	Bristol Myers Squibb Co This page	3,600	$207,432

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$207,432	3,600	-36.8%	Shares	Sole	2026-08-13
2025-06-30	$263,853	5,700	-44.1%	Shares	Sole	2025-08-14
2025-03-31	$622,098	10,200	+1.7%	Shares	Sole	2025-05-16
2024-06-30	$416,712	10,034	—	Shares	Sole	2024-08-02
No filing history on record for this holder in this stock.